Home/Filings/4/0001140361-22-026995
4//SEC Filing

Hyman Steven 4

Accession 0001140361-22-026995

CIK 0001755237other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 4:33 PM ET

Size

4.9 KB

Accession

0001140361-22-026995

Insider Transaction Report

Form 4
Period: 2022-07-25
Hyman Steven
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-25+57,75357,753 total
    Exercise: $0.78Exp: 2032-07-25Common Stock (57,753 underlying)
Footnotes (1)
  • [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.

Issuer

Cyclerion Therapeutics, Inc.

CIK 0001755237

Entity typeother

Related Parties

1
  • filerCIK 0001656506

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:33 PM ET
Size
4.9 KB